
Biostate AI is a biotechnology company revolutionizing healthcare through next-generation RNA sequencing and artificial intelligence. They have developed proprietary RNA sequencing technologies that drastically reduce costs by 50-70%, enabling large-scale data collection essential for AI-driven personalized medicine. Their integrated platform includes RNA sequencing services, AI-powered bioinformatics tools like OmicsWeb, Copilot, and QuantaQuill, which democratize complex data analysis for researchers without specialized expertise. Biostate AI aims to build the world's largest RNA sequencing database to train foundation AI models that predict disease outcomes and treatment responses, ultimately enabling personalized therapeutics. The company serves academic labs, pharmaceutical R&D, biobanks, clinical oncology research, and biotech startups, positioning itself as a leader in affordable, AI-enhanced molecular diagnostics with a global presence and strategic partnerships with top medical institutions.

Biostate AI is a biotechnology company revolutionizing healthcare through next-generation RNA sequencing and artificial intelligence. They have developed proprietary RNA sequencing technologies that drastically reduce costs by 50-70%, enabling large-scale data collection essential for AI-driven personalized medicine. Their integrated platform includes RNA sequencing services, AI-powered bioinformatics tools like OmicsWeb, Copilot, and QuantaQuill, which democratize complex data analysis for researchers without specialized expertise. Biostate AI aims to build the world's largest RNA sequencing database to train foundation AI models that predict disease outcomes and treatment responses, ultimately enabling personalized therapeutics. The company serves academic labs, pharmaceutical R&D, biobanks, clinical oncology research, and biotech startups, positioning itself as a leader in affordable, AI-enhanced molecular diagnostics with a global presence and strategic partnerships with top medical institutions.
Founded: 2023
Headquarters: Houston, TX
Core offering: Low-cost RNA sequencing wetlab + AI bioinformatics platform
Total funding: $16M
Notable lead investor: Accel (Series A, 2025)
| Company |
|---|
Affordable, scalable multi-omics data generation and AI-driven interpretation for disease prediction, drug discovery, and clinical decision support.
2023
Biotechnology Research
$12M
Series A announced May 20–21, 2025
“Backed by institutional and high-profile individual investors including Accel, Caltech, Gaingels, Matter Venture Partners and individual backers such as Dario Amodei and Emily Leproust.”
Location:
Remote
About Biostate AI
Biostate AI is a biotechnology company advancing the predictive power of biology through high-throughput multi-omic data generation and AI-driven analysis. We collaborate with leading academic and clinical institutions to accelerate research and enable real-time biological insight at scale.
Role Overview
Biostate AI is seeking an outgoing, personable, and creative Digital Media & PR Intern to support short-form video content creation, with a strong emphasis on street interviews and on-camera interactions.
This role is ideal for someone who is comfortable approaching people, asking engaging questions, and helping capture authentic, human-centered moments for short videos. Additional responsibilities may include assisting with video editing, content planning, and digital media coordination.
Responsibilities
Preferred Qualifications
Time Commitment
10-20 hours per week (flexible schedule)
Compensation
$1,000-2,000 per month